Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James R. Kasinger currently holds 87,815 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Kasinger has been a net seller of CRSP stock. They have purchased $0 and sold $6.4M worth of shares.
James R. Kasinger's most recent insider trade was on Mar 11, 2026, when they sold 2,800 shares at $52.80 per share.
James R. Kasinger serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 48 insider transactions totaling $6.4M over their tenure at the company.
James R. Kasinger holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
James R. Kasinger has shown a selling trading pattern, with $0 in total purchases and $6.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James R. Kasinger was on Jan 19, 2021, when they sold $1.8M worth of CRSP shares. This transaction involved 8,997 shares at $205.60 per share.
James R. Kasinger currently owns 87,815 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James R. Kasinger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James R. Kasinger has 48 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for James R. Kasinger and 40,000+ other insiders.